|
1
|
Are Frozen Foods a Public Health Problem?
|
Am J Public Health Nations Health
|
1947
|
3.44
|
|
2
|
Biomarkers of oxidative stress study II: are oxidation products of lipids, proteins, and DNA markers of CCl4 poisoning?
|
Free Radic Biol Med
|
2005
|
3.13
|
|
3
|
The Concise Guide to PHARMACOLOGY 2013/14: overview.
|
Br J Pharmacol
|
2013
|
2.48
|
|
4
|
No evidence for lipid peroxidation in severe preeclampsia.
|
Am J Obstet Gynecol
|
2001
|
2.28
|
|
5
|
Increased F2-isoprostanes in Alzheimer's disease: evidence for enhanced lipid peroxidation in vivo.
|
FASEB J
|
1998
|
1.89
|
|
6
|
Nicotine effects on eicosanoid formation and hemostatic function: comparison of transdermal nicotine and cigarette smoking.
|
J Am Coll Cardiol
|
1993
|
1.76
|
|
7
|
Brain metabolism in teenagers with attention-deficit hyperactivity disorder.
|
Arch Gen Psychiatry
|
1993
|
1.60
|
|
8
|
Effect of oral prednisone on airway inflammatory mediators in atopic asthma.
|
Am J Respir Crit Care Med
|
1994
|
1.54
|
|
9
|
Human platelet/erythroleukemia cell prostaglandin G/H synthase: cDNA cloning, expression, and gene chromosomal assignment.
|
FASEB J
|
1991
|
1.54
|
|
10
|
Measurement of 6-oxo-PGF1 alpha in human plasma using gas chromatography-mass spectrometry.
|
Prostaglandins
|
1979
|
1.48
|
|
11
|
Biomarkers of oxidative stress study III. Effects of the nonsteroidal anti-inflammatory agents indomethacin and meclofenamic acid on measurements of oxidative products of lipids in CCl4 poisoning.
|
Free Radic Biol Med
|
2005
|
1.42
|
|
12
|
Immunological characterization of urinary 8-epi-prostaglandin F2 alpha excretion in man.
|
J Pharmacol Exp Ther
|
1995
|
1.38
|
|
13
|
Paracetemol poisoning--a brief report.
|
Ir Med J
|
1977
|
1.32
|
|
14
|
The human thromboxane A2 receptor alpha isoform (TP alpha) functionally couples to the G proteins Gq and G11 in vivo and is activated by the isoprostane 8-epi prostaglandin F2 alpha.
|
J Pharmacol Exp Ther
|
1997
|
1.31
|
|
15
|
Circadian rhythm of baroreflex reactivity and adrenergic vascular response.
|
Cardiovasc Res
|
1980
|
1.15
|
|
16
|
Sanitation and Quality Control in the Fishery Industries.
|
Am J Public Health Nations Health
|
1937
|
1.15
|
|
17
|
Chronic obstructive pulmonary disease is associated with an increase in urinary levels of isoprostane F2alpha-III, an index of oxidant stress.
|
Am J Respir Crit Care Med
|
1998
|
1.12
|
|
18
|
Increased excretion of leukotriene E4 during aspirin-induced asthma.
|
J Lab Clin Med
|
1992
|
1.11
|
|
19
|
Biosynthesis of thromboxane in patients with systemic sclerosis and Raynaud's phenomenon.
|
Br Med J (Clin Res Ed)
|
1986
|
1.10
|
|
20
|
Allergen-stimulated release of thromboxane A2 and leukotriene E4 in humans. Effect of indomethacin.
|
Am Rev Respir Dis
|
1990
|
1.08
|
|
21
|
Point mutation in the seventh hydrophobic domain of the human thromboxane A2 receptor allows discrimination between agonist and antagonist binding sites.
|
Mol Pharmacol
|
1993
|
1.07
|
|
22
|
Role of thrombin and thromboxane A2 in reocclusion following coronary thrombolysis with tissue-type plasminogen activator.
|
Proc Natl Acad Sci U S A
|
1989
|
1.04
|
|
23
|
Circulating adrenaline and blood pressure: the metabolic effects and kinetics of infused adrenaline in man.
|
Eur J Clin Invest
|
1980
|
1.04
|
|
24
|
Circadian variation in adrenergic responses in asthmatic subjects.
|
Clin Sci (Lond)
|
1982
|
1.00
|
|
25
|
Measurement of renal and non-renal eicosanoid synthesis.
|
Am J Med
|
1986
|
0.99
|
|
26
|
Allergen-stimulated release of mediators into sheep bronchoalveolar lavage fluid. Effect of cyclooxygenase inhibition.
|
Am Rev Respir Dis
|
1989
|
0.96
|
|
27
|
Long-lived enzymatic metabolites of thromboxane B2 in the human circulation.
|
Anal Biochem
|
1986
|
0.95
|
|
28
|
Microsomal prostaglandin E synthase-1 inhibition in cardiovascular inflammatory disease.
|
J Intern Med
|
2008
|
0.94
|
|
29
|
Reduced brain metabolism in hyperactive girls.
|
J Am Acad Child Adolesc Psychiatry
|
1994
|
0.93
|
|
30
|
Heterogeneity of prostaglandin H2/thromboxane A2 receptors: distinct subtypes mediate vascular smooth muscle contraction and platelet aggregation.
|
J Pharmacol Exp Ther
|
1991
|
0.93
|
|
31
|
Endogenous prostacyclin synthesis is decreased during activation of the renin-angiotensin system in man.
|
J Clin Endocrinol Metab
|
1984
|
0.90
|
|
32
|
Cellular activation by thromboxane A2 and other eicosanoids.
|
Eur Heart J
|
1993
|
0.89
|
|
33
|
Immunotargeting of glucose oxidase to endothelium in vivo causes oxidative vascular injury in the lungs.
|
Am J Physiol Lung Cell Mol Physiol
|
2000
|
0.89
|
|
34
|
Biopharmaceutical characterisation of a low-dose (75 mg) controlled-release aspirin formulation.
|
Br J Clin Pharmacol
|
1993
|
0.89
|
|
35
|
Leukotriene B4 synthesis and neutrophil chemotaxis in chronic granulocytic leukaemia.
|
J Clin Pathol
|
1988
|
0.88
|
|
36
|
Assessment of the extent to exogenous prostaglandin I2 is converted to 6-keto-prostaglandin E1 in human subjects.
|
J Pharmacol Exp Ther
|
1982
|
0.87
|
|
37
|
The immunogenicity of Haemophilus influenzae type b conjugate vaccines in children born to human immunodeficiency virus-infected women. Women and Infants Transmission Study Group.
|
Pediatr Infect Dis J
|
1998
|
0.86
|
|
38
|
Intravenous prostacyclin in thrombotic thrombocytopenic purpura.
|
Ann Intern Med
|
1981
|
0.84
|
|
39
|
The translational therapeutics of prostaglandin inhibition in atherothrombosis.
|
J Thromb Haemost
|
2009
|
0.83
|
|
40
|
Thromboxane biosynthesis in allergen-induced bronchospasm. Evidence for platelet activation.
|
Am Rev Respir Dis
|
1989
|
0.81
|
|
41
|
Effects of dietary fat content, saturated fatty acids, and fish oil on eicosanoid production and hemostatic parameters in normal men.
|
J Lab Clin Med
|
1994
|
0.80
|
|
42
|
Eicosanoid biosynthesis in human cardiovascular disease.
|
Hum Pathol
|
1987
|
0.80
|
|
43
|
Excretion of prostacyclin and thromboxane A2 metabolites during leg exercise in humans.
|
Am J Physiol
|
1988
|
0.80
|
|
44
|
Effects of intravenous dextroamphetamine on brain metabolism in adults with attention-deficit hyperactivity disorder (ADHD). Preliminary findings.
|
Psychopharmacol Bull
|
1994
|
0.79
|
|
45
|
Aspirin reduces the prothrombotic activity of C-reactive protein.
|
J Thromb Haemost
|
2009
|
0.78
|
|
46
|
No evidence for antagonism of clonidine by naloxone in man [proceedings].
|
Br J Clin Pharmacol
|
1980
|
0.78
|
|
47
|
Pre and postsynaptic alpha-receptor agonists and the rate of release of noradrenaline in man [proceedings].
|
Br J Clin Pharmacol
|
1979
|
0.78
|
|
48
|
Cyclooxygenase-dependent formation of the isoprostane 8-epi prostaglandin F2 alpha.
|
Ann N Y Acad Sci
|
1994
|
0.78
|
|
49
|
Enhanced monocyte expression of tissue factor by oxidative stress in patients with antiphospholipid antibodies: effect of antioxidant treatment.
|
J Thromb Haemost
|
2003
|
0.78
|
|
50
|
Histocompatibility antigens and haemochromatosis in Ireland.
|
Ir J Med Sci
|
1980
|
0.78
|
|
51
|
Cellular activation of thromboxane receptors.
|
Ann N Y Acad Sci
|
1994
|
0.77
|
|
52
|
Molecular cloning of the human platelet 12-lipoxygenase.
|
Trans Assoc Am Physicians
|
1990
|
0.77
|
|
53
|
A prostacyclin analog impairs the response to tissue-type plasminogen activator during coronary thrombolysis: evidence for a pharmacokinetic interaction.
|
J Pharmacol Exp Ther
|
1991
|
0.77
|
|
54
|
Comparative impact on prostanoid biosynthesis of celecoxib and the novel nonsteroidal anti-inflammatory drug CG100649.
|
Clin Pharmacol Ther
|
2012
|
0.77
|
|
55
|
The effect of prostacyclin on pituitary hormone release.
|
Br J Clin Pharmacol
|
1980
|
0.76
|
|
56
|
Cyclooxygenase dependent formation of 8-iso-prostaglandin F2 alpha by human platelets.
|
Adv Prostaglandin Thromboxane Leukot Res
|
1995
|
0.76
|
|
57
|
Cellular activation by thromboxane A2 and 8-EPI-PGF2 alpha.
|
Adv Exp Med Biol
|
1997
|
0.76
|
|
58
|
Vovulus of the small bowel in a diabetic patient.
|
Br Med J
|
1976
|
0.75
|
|
59
|
Consequences dietary ethanol on permeability and respiration of mitochondria and liver ADH in young and aged rats.
|
Curr Alcohol
|
1979
|
0.75
|
|
60
|
Prostaglandins.
|
Ir Med J
|
1982
|
0.75
|
|
61
|
Antiplatelet and anticoagulant therapy during coronary thrombolysis.
|
Trends Cardiovasc Med
|
2011
|
0.75
|
|
62
|
One hundred days in a general medical/specialist unit--sources of referral and length of hospital stay.
|
Ir Med J
|
1979
|
0.75
|
|
63
|
Vascular effects of infused adenosine are not mediated by prostacyclin release in humans.
|
Am J Physiol
|
1987
|
0.75
|
|
64
|
Digitoxin-quinidine interaction: potentiation during administration of cimetidine.
|
South Med J
|
1981
|
0.75
|
|
65
|
Health Problems in Packing Crustacean Products.
|
Am J Public Health Nations Health
|
1939
|
0.75
|
|
66
|
Cryoglobulinaemia in Henoch-Schönlein purpura.
|
Br Med J
|
1977
|
0.75
|
|
67
|
Erythrocytes catechol-O-methyltransferase activity and indices of sympathetic activity in man.
|
Clin Sci (Lond)
|
1980
|
0.75
|
|
68
|
Beta-adrenoreceptor down-regulation by dynamic exercise and upright posture in man.
|
Trans Assoc Am Physicians
|
1981
|
0.75
|
|
69
|
Hypertensive crisis in prazosin-treated pheochromocytoma.
|
South Med J
|
1984
|
0.75
|
|
70
|
The kinetics and concentration-effect relationships of circulating adrenaline in man [proceedings].
|
Br J Clin Pharmacol
|
1980
|
0.75
|
|
71
|
HLA identity in juvenile onset diabetes.
|
Ir J Med Sci
|
1978
|
0.75
|